MICHAEL J MAURO

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology NEW YORK, NY NPI 1609884188

General Payments — all program years on this page

$258,176.41

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 172
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $24,350.04 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $22,400.007
Travel and Lodging $1,193.972
Food and Beverage $756.074

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $21,484.2310
Novartis Pharma AG $2,834.212
PFIZER INC. $31.601

By program year

Program yearAmountRecords
2018 $54,786.9970
2019 $83,838.0239
2020 $26,601.5315
2021 $11,861.008
2022 $36,158.7716
2023 $20,580.0611
2024 $24,350.0413

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087138832 Novartis Pharmaceuticals Corporation $1,200.00 02/16/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087155158 Novartis Pharmaceuticals Corporation $1,600.00 08/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087155160 Novartis Pharmaceuticals Corporation $2,400.00 10/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087155162 Novartis Pharmaceuticals Corporation $2,800.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087155164 Novartis Pharmaceuticals Corporation $563.47 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087155166 Novartis Pharmaceuticals Corporation $126.79 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087155168 Novartis Pharmaceuticals Corporation $795.98 05/30/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1087155170 Novartis Pharmaceuticals Corporation $397.99 05/30/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1087155172 Novartis Pharmaceuticals Corporation $5,200.00 05/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087155174 Novartis Pharmaceuticals Corporation $6,400.00 01/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1131587014 PFIZER INC. $31.60 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152815185 Novartis Pharma AG $2,800.00 01/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1152815277 Novartis Pharma AG $34.21 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.